EPCAM deletions, Lynch syndrome, and cancer risk

Henry T. Lynch, Jane F. Lynch, Carrie L. Snyder, Douglas Riegert-Johnson

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)5-6
Number of pages2
JournalThe Lancet Oncology
Volume12
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

MutS Homolog 2 Protein
Hereditary Nonpolyposis Colorectal Neoplasms
Gene Deletion
Cell Adhesion Molecules
Neoplasm Antigens
Endometrial Neoplasms
Colorectal Neoplasms
Mutation
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Lynch, H. T., Lynch, J. F., Snyder, C. L., & Riegert-Johnson, D. (2011). EPCAM deletions, Lynch syndrome, and cancer risk. The Lancet Oncology, 12(1), 5-6. https://doi.org/10.1016/S1470-2045(10)70291-6

EPCAM deletions, Lynch syndrome, and cancer risk. / Lynch, Henry T.; Lynch, Jane F.; Snyder, Carrie L.; Riegert-Johnson, Douglas.

In: The Lancet Oncology, Vol. 12, No. 1, 01.2011, p. 5-6.

Research output: Contribution to journalArticle

Lynch, HT, Lynch, JF, Snyder, CL & Riegert-Johnson, D 2011, 'EPCAM deletions, Lynch syndrome, and cancer risk', The Lancet Oncology, vol. 12, no. 1, pp. 5-6. https://doi.org/10.1016/S1470-2045(10)70291-6
Lynch, Henry T. ; Lynch, Jane F. ; Snyder, Carrie L. ; Riegert-Johnson, Douglas. / EPCAM deletions, Lynch syndrome, and cancer risk. In: The Lancet Oncology. 2011 ; Vol. 12, No. 1. pp. 5-6.
@article{5657d70f6bed40d18295790c2f0658b1,
title = "EPCAM deletions, Lynch syndrome, and cancer risk",
author = "Lynch, {Henry T.} and Lynch, {Jane F.} and Snyder, {Carrie L.} and Douglas Riegert-Johnson",
year = "2011",
month = "1",
doi = "10.1016/S1470-2045(10)70291-6",
language = "English (US)",
volume = "12",
pages = "5--6",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "1",

}

TY - JOUR

T1 - EPCAM deletions, Lynch syndrome, and cancer risk

AU - Lynch, Henry T.

AU - Lynch, Jane F.

AU - Snyder, Carrie L.

AU - Riegert-Johnson, Douglas

PY - 2011/1

Y1 - 2011/1

UR - http://www.scopus.com/inward/record.url?scp=78650713193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650713193&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(10)70291-6

DO - 10.1016/S1470-2045(10)70291-6

M3 - Article

C2 - 21195320

AN - SCOPUS:78650713193

VL - 12

SP - 5

EP - 6

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 1

ER -